5-amino-1mq nnmt inhibitor small molecule 5-Amino-1MQ Research Compound | Laboratory

Route Topical / transdermal Published Dose Context Marketed by some clinics and compounders, but no published human exposure data was identified in FDA's December 2024 evaluation

After that, they need a shot every month

Impaired activity of methionine synthase results in elevated blood concentrations of homocysteine, while impaired activity of L-methylmalonyl-CoA mutase results in increased concentrations of a metabolite of methylmalonyl-CoA called methylmalonic acid (MMA) in blood and urine

AOD 9604 is an investigational peptide that requires a licensed medical provider, prescription, and clinical oversight

Ingredients are sourced from carefully vetted, FDA-inspected facilities